PeptideStack
5.2kquestions
20kanswers
220users

Why did my TSH move after six weeks on liraglutide?

Asked 20 Jul 2025Modified 12 months agoViewed 18k times
This question was marked as a duplicate of Why did my albumin-to-creatinine ratio move after sixteen weeks on tirzepatide?Closed 21 Aug 2025. It remains here because the answers below are specific to how it was asked.
21

Details up front: TSH · six weeks · liraglutide.

Before I write this off, I want to check whether it is a known failure mode.

I have the lot number, the certificate and the date, and I am happy to compare them against anything.

What would you check first, and what would you conclude from each outcome?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

284 questionskidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

100 questionslipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

112 questions
shareeditfollowflag
DS
askeddmitri_savchuk17k1620 Jul 2025
5The timing signature is the useful part. Everything else is confounded. – vialroom 8 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 18k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.